{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:33:43Z","timestamp":1790782423655,"version":"4.1.0"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T00:00:00Z","timestamp":1416268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s12020-014-0474-9","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T16:19:49Z","timestamp":1416586789000},"page":"339-352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Italian Association of Clinical Endocrinologists (AME) &amp; Italian Association of Clinical Diabetologists (AMD) Position Statement"],"prefix":"10.1007","volume":"49","author":[{"given":"Edoardo","family":"Guastamacchia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Triggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Aglialoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antimo","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Maccario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Zini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Giorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinaldo","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Betterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Attanasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Borretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piernicola","family":"Garofalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Papini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Castello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ceriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,18]]},"reference":[{"key":"474_CR1","unstructured":"GRADE Working Group website http:\/\/www.gradeworkinggroup.org . (no LoE)"},{"issue":"7454","key":"474_CR2","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"D Atkins","year":"2004","unstructured":"D. Atkins, D. Best, P.A. Briss, M. Eccles, Y. Falck-Ytter, S. Flottorp, G.H. Guyatt, R.T. Harbour, M.C. Haugh, D. Henry, S. Hill, R. Jaeschke, G. Leng, A. Liberati, N. Magrini, J. Mason, P. Middleton, J. Mrukowicz, D. O\u2019Connell, A.D. Oxman, B. Phillips, H.J. Sch\u00fcnemann, T. Edejer, H. Varonen, G.E. Vist, J.W. Williams Jr, S. Zaza, GRADE Working Group, Grading quality of evidence and strength of recommendations. BMJ 328(7454), 1490 (2004). (no LoE)","journal-title":"BMJ"},{"issue":"3","key":"474_CR3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1210\/jc.2007-1907","volume":"93","author":"BA Swiglo","year":"2008","unstructured":"B.A. Swiglo, M.H. Murad, H.J. Sch\u00fcnemann, R. Kunz, R.A. Vigersky, G.H. Guyatt, V.M. Montori, A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J. Clin. Endocrinol. Metab. 93(3), 666\u2013673 (2008). doi: 10.1210\/jc.2007-1907 . (no LoE)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7650","key":"474_CR4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"G.H. Guyatt, A.D. Oxman, G.E. Vist, R. Kunz, Y. Falck-Ytter, P. Alonso-Coello, H.J. Sch\u00fcnemann, GRADE Working Group, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650), 924\u2013926 (2008). doi: 10.1136\/bmj.39489.470347.AD . (no LoE)","journal-title":"BMJ"},{"issue":"2","key":"474_CR5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4158\/EP.16.2.270","volume":"16","author":"JI Mechanick","year":"2010","unstructured":"J.I. Mechanick, P.M. Camacho, R.H. Cobin, A.J. Garber, J.R. Garber, H. Gharib, S.M. Petak, H.W. Rodbard, D.L. Trence, American Association of Clinical Endocrinologists, Protocol for standardized production of clinical practice guidelines-2010 update. Endocr. Pract. 16(2), 270\u2013283 (2010). (no LoE)","journal-title":"Endocr. Pract."},{"key":"474_CR6","first-page":"398","volume-title":"Werne and Ingbar\u2019s the thryoid: a fundamental and clinical text","author":"MPJ Vanderpump","year":"2005","unstructured":"M.P.J. Vanderpump, The epidemiology of thyroid diseases, in Werner and Ingbar\u2019s the thryoid: a fundamental and clinical text, ed. by L.E. Braverman, R.D. Utiger (J.B. Lippicott-Raven, Philadelphia, 2005), pp. 398\u2013496"},{"issue":"2","key":"474_CR7","first-page":"561","volume":"84","author":"F Aghini-Lombardi","year":"1999","unstructured":"F. Aghini-Lombardi, L. Antonangeli, E. Martino, P. Vitti, D. Maccherini, F. Leoli, T. Rago, L. Grasso, R. Valeriano, A. Balestrieri, A. Pinchera, The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin. Endocrinol. Metab. 84(2), 561\u2013566 (1999). (LoE )","journal-title":"J Clin. Endocrinol. Metab."},{"issue":"6","key":"474_CR8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1977.tb01340.x","volume":"7","author":"WM Tunbridge","year":"1977","unstructured":"W.M. Tunbridge, D.C. Evered, R. Hall, D. Appleton, M. Brewis, F. Clark, J.G. Evans, E. Young, T. Bird, P.A. Smith, The spectrum of thyroid disease in a community: the Whickham survey. Clin. Endocrinol. (Oxford) 7(6), 481\u2013493 (1977). (LoE )","journal-title":"Clin. Endocrinol. (Oxford)"},{"issue":"1","key":"474_CR9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2265.1995.tb01894.x","volume":"43","author":"MP Vanderpump","year":"1995","unstructured":"M.P. Vanderpump, W.M. Tunbridge, J.M. French, D. Appleton, D. Bates, F. Clark, J. Grimley Evans, D.M. Hasan, H. Rodgers, F. Tunbridge, E.T. Young, The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin. Endocrinol. (Oxford) 43(1), 55\u201368 (1995). (LoE )","journal-title":"Clin. Endocrinol. (Oxford)"},{"issue":"1","key":"474_CR10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2265.1991.tb01739.x","volume":"34","author":"JV Parle","year":"1991","unstructured":"J.V. Parle, J.A. Franklyn, K.W. Cross, S.C. Jones, M.C. Sheppard, Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin. Endocrinol. (Oxford) 34(1), 77\u201383 (1991). (LoE )","journal-title":"Clin. Endocrinol. (Oxford)"},{"key":"474_CR11","unstructured":"ISTAT (2012) www.istat.it\/it\/archivio\/71090 . (no LoE)"},{"issue":"5","key":"474_CR12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2337\/diacare.6.5.512","volume":"6","author":"M Mouradian","year":"1983","unstructured":"M. Mouradian, N. Abourizk, Diabetes mellitus and thyroid disease. Diabetes Care 6(5), 512\u2013520 (1983). (no LoE)","journal-title":"Diabetes Care"},{"issue":"6202","key":"474_CR13","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1136\/bmj.2.6202.1439-a","volume":"2","author":"RS Gray","year":"1979","unstructured":"R.S. Gray, W.J. Irvine, B.F. Clarke, Screening for thyroid dysfunction in diabetics. Br. Med. J. 2(6202), 1439 (1979). (no LoE)","journal-title":"Br. Med. J."},{"issue":"1","key":"474_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2011.04029.x","volume":"75","author":"LH Duntas","year":"2011","unstructured":"L.H. Duntas, J. Orgiazzi, G. Brabant, The interface between thyroid and diabetes mellitus. Clin. Endocrinol. (Oxford) 75(1), 1\u20139 (2011). doi: 10.1111\/j.1365-2265.2011.04029.x","journal-title":"Clin. Endocrinol. (Oxford)"},{"issue":"8","key":"474_CR15","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1742-1241.2010.02376.x","volume":"64","author":"R Kadiyala","year":"2010","unstructured":"R. Kadiyala, R. Peter, O.E. Okosieme, Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies. Int. J. Clin. Pract. 64(8), 1130\u20131139 (2010). doi: 10.1111\/j.1742-1241.2010.02376.x . (LoE )","journal-title":"Int. J. Clin. Pract."},{"issue":"7","key":"474_CR16","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1464-5491.1995.tb00553.x","volume":"12","author":"P Perros","year":"1995","unstructured":"P. Perros, R.J. McCrimmon, G. Shaw, B.M. Frier, Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet. Med. 12(7), 622\u2013627 (1995)","journal-title":"Diabet. Med."},{"issue":"4","key":"474_CR17","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2337\/diacare.26.4.1181","volume":"26","author":"GE Umpierrez","year":"2003","unstructured":"G.E. Umpierrez, K.A. Latif, M.B. Murphy, H.C. Lambeth, F. Stentz, A. Bush, A.E. Kitabch, Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. Diabetes Care 26(4), 1181\u20131185 (2003). (LoE )","journal-title":"Diabetes Care"},{"issue":"7","key":"474_CR18","first-page":"235","volume":"65","author":"LC Graaff de","year":"2007","unstructured":"L.C. de Graaff, J.W. Smit, J.K. Radder, Prevalence and clinical significance of organ-specific autoantibodies in type 1 diabetes mellitus. Neth. J. Med. 65(7), 235\u2013247 (2007). (no LoE)","journal-title":"Neth. J. Med."},{"issue":"7309","key":"474_CR19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(63)90448-3","volume":"2","author":"JM Moore","year":"1963","unstructured":"J.M. Moore, J.M. Neilson, Antibodies to gastric mucosa and thyroid in diabetes mellitus. Lancet. 2(7309), 645\u2013647 (1963). (LoE )","journal-title":"Lancet."},{"issue":"2","key":"474_CR20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0022-3476(70)80342-0","volume":"77","author":"DE Goldstein","year":"1970","unstructured":"D.E. Goldstein, A. Drasch, J. Gibbs, R.M. Blizzard, Diabetes mellitus: the incidence of circulating antibodies against thyroid, gastric, and adrenal tissue. J. Pediatr. 77(2), 304\u2013306 (1970). (LoE )","journal-title":"J. Pediatr."},{"issue":"7665","key":"474_CR21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(70)92531-6","volume":"2","author":"WJ Irvine","year":"1970","unstructured":"W.J. Irvine, B.F. Clarke, L. Scarth, D.R. Cullen, L.J. Duncan, Thyroid and gastric autoimmunity in patients with diabetes mellitus. Lancet 2(7665), 163\u2013168 (1970)","journal-title":"Lancet"},{"issue":"2","key":"474_CR22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1530\/acta.0.0720279","volume":"72","author":"J Nerup","year":"1973","unstructured":"J. Nerup, C. Binder, Thyroid, gastric and adrenal auto-immunity in diabetes mellitus. Acta. Endocrinol. (Copenh) 72(2), 279\u2013286 (1973). (LoE )","journal-title":"Acta. Endocrinol. (Copenh)"},{"issue":"8","key":"474_CR23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2337\/diab.29.8.589","volume":"29","author":"M Neufeld","year":"1980","unstructured":"M. Neufeld, N.K. Maclaren, W.J. Riley, D. Lezotte, J.V. McLaughlin, J. Silverstein, A.L. Rosenbloom, Islet cell and other organ-specific antibodies in U.S. Caucasians and Blacks with insulin-dependent diabetes mellitus. Diabetes 29(8), 589\u2013592 (1980). (LoE )","journal-title":"Diabetes"},{"issue":"3","key":"474_CR24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0022-3476(81)80316-2","volume":"99","author":"WJ Riley","year":"1981","unstructured":"W.J. Riley, N.K. Maclaren, D.C. Lezotte, R.P. Spillar, A.L. Rosenbloom, Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J. Pediatr. 99(3), 350\u2013354 (1981). (LoE )","journal-title":"J. Pediatr."},{"key":"474_CR25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/adc.57.8.622","volume":"57","author":"S Court","year":"1982","unstructured":"S. Court, J.M. Parkin, Hypothyroidism and growth failure in diabetes mellitus. Arch. Dis. Child. 57, 622\u2013624 (1982). (LoE )","journal-title":"Arch. Dis. Child."},{"issue":"2","key":"474_CR26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1651-2227.1982.tb09403.x","volume":"71","author":"J Kokkonen","year":"1982","unstructured":"J. Kokkonen, J. Kiuttu, A. Mustonen, O. R\u00e4s\u00e4nen, Organ-specific antibodies in healthy and diabetic children and young adults. Acta. Pediatr. Scand. 71(2), 223\u2013226 (1982). (LoE )","journal-title":"Acta. Pediatr. Scand."},{"issue":"2","key":"474_CR27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0022-3476(84)80116-X","volume":"105","author":"BB Gilani","year":"1984","unstructured":"B.B. Gilani, M.H. MacGillivray, M.L. Voorhess, B.J. Mills, W.J. Riley, N.K. MacLaren, Thyroid hormone abnormalities at diagnosis of insulin-dependent diabetes mellitus in children. J. Pediatr. 105(2), 218\u2013222 (1984). (LoE )","journal-title":"J. Pediatr."},{"issue":"Suppl 1","key":"474_CR28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/diacare.8.1.S34","volume":"8","author":"NK Maclaren","year":"1985","unstructured":"N.K. Maclaren, W.J. Riley, Thyroid, gastric, and adrenal autoimmunities associated with insulin-dependent diabetes mellitus. Diabetes Care 8(Suppl 1), 34\u201338 (1985). (LoE )","journal-title":"Diabetes Care"},{"issue":"3","key":"474_CR29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF00274217","volume":"30","author":"DW Drell","year":"1987","unstructured":"D.W. Drell, A.L. Notkins, Multiple immunological abnormalities in patients with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 30(3), 132\u2013143 (1987). (no LoE)","journal-title":"Diabetologia."},{"issue":"4","key":"474_CR30","first-page":"151","volume":"13","author":"S Kontiainen","year":"1990","unstructured":"S. Kontiainen, A. Schlenzka, S. Koskimies, A. Rilva, J. M\u00e4enp\u00e4\u00e4, Autoantibodies and autoimmune diseases in young diabetics. Diabetes Res. 13(4), 151\u2013156 (1990). (LoE )","journal-title":"Diabetes Res."},{"issue":"8","key":"474_CR31","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.2337\/diab.41.8.1022","volume":"41","author":"M Landin-Olsson","year":"1992","unstructured":"M. Landin-Olsson, F.A. Karlsson, A. Lernmark, G. Sundkvist, Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the diabetes incidence study in Sweden. Diabetes 41(8), 1022\u20131027 (1992). (LoE )","journal-title":"Diabetes"},{"issue":"2","key":"474_CR32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00569570","volume":"32","author":"G Radetti","year":"1995","unstructured":"G. Radetti, C. Paganini, L. Gentili, S. Bernasconi, C. Betterle, M. Borkenstein, K. Cvijovic, M. Kadrnka-Lovrencic, C. Krzisnik, T. Battelino, R. Lorini, S. Marinoni, F. Rigon, L. Tat\u00f2, L. Pinelli, G. Tonini, Frequency of Hashimoto\u2019s thyroiditis in children with type 1 diabetes mellitus. Acta Diabetol. 32(2), 121\u2013124 (1995). (Loe ) doi: 10.1007\/BF00569570","journal-title":"Acta Diabetol."},{"issue":"5","key":"474_CR33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/(SICI)1096-9136(199605)13:5<415::AID-DIA96>3.0.CO;2-X","volume":"13","author":"P Abrams","year":"1996","unstructured":"P. Abrams, I. De Leeuw, J. Vertommen, In new-onset insulin-dependent diabetic patients the presence of anti-thyroid peroxidase antibodies is associated with islet cell autoimmunity and the high risk haplotype HLA DQA1*0301-DQB1*0302. Belgian Diabetes Registry. Diabet. Med. 13(5), 415\u2013419 (1996). (LoE )","journal-title":"Diabet. Med."},{"issue":"Suppl 1","key":"474_CR34","first-page":"95","volume":"9","author":"IG Jefferson","year":"1996","unstructured":"I.G. Jefferson, The clinical approach to thyroid disorders associated with childhood insulin dependent diabetes mellitus. J. Pediatr. Endocrinol. Metab. 9(Suppl 1), 95\u2013100 (1996). (no LoE)","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"Suppl 1","key":"474_CR35","first-page":"89","volume":"9","author":"R Lorini","year":"1996","unstructured":"R. Lorini, G. d\u2019Annunzio, L. Vitali, A. Scaramuzza, IDDM and autoimmune thyroid disease in the pediatric age group. J. Pediatr. Endocrinol. Metab. 9(Suppl 1), 89\u201394 (1996). (LoE )","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"5","key":"474_CR36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1515\/JPEM.1997.10.5.455","volume":"10","author":"F Presotto","year":"1997","unstructured":"F. Presotto, C. Betterle, Insulin-dependent diabetes mellitus: a constellation of autoimmune diseases. J. Pediatr. Endocrinol. Metab. 10(5), 455\u2013469 (1997). (no LoE)","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"5","key":"474_CR37","first-page":"1548","volume":"83","author":"E McCanlies","year":"1998","unstructured":"E. McCanlies, L.A. O\u2019Leary, T.P. Foley, M.K. Kramer, J.P. Burke, A. Libman, J.S. Swan, A.R. Steenkiste, B.J. Mccarthy, M. Trucco, J.S. Dorman, Hashimoto\u2019s thyroiditis and insulin-dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function. J. Clin. Endocrinol. Metab. 83(5), 1548\u20131551 (1998). (LoE )","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"474_CR38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1530\/eje.0.1390044","volume":"139","author":"CC Chang","year":"1998","unstructured":"C.C. Chang, C.N. Huang, L.M. Chuang, Autoantibodies to thyroid peroxidase in patients with type 1 diabetes in Taiwan. Eur. J. Endocrinol. 139(1), 44\u201348 (1998). (LoE )","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"474_CR39","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1530\/eje.0.1400512","volume":"140","author":"D Hansen","year":"1999","unstructured":"D. Hansen, F.N. Bennedbaek, L.K. Hansen, M. Hoier-Madsen, B.B. Jacobsen, L. Heged\u00fcs, Thyroid function, morphology and autoimmunity in young patients with insulin-dependent diabetes mellitus. Eur. J. Endocrinol. 140(6), 512\u2013518 (1999). (Loe )","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"474_CR40","first-page":"27","volume":"12","author":"MB Rold\u00e1n","year":"1999","unstructured":"M.B. Rold\u00e1n, M. Alonso, R. Barrio, Thyroid autoimmunity in children and adolescents with Type 1 diabetes mellitus. Diabetes Nutr. Metab. 12(1), 27\u201331 (1999). (LoE )","journal-title":"Diabetes Nutr. Metab."},{"issue":"5","key":"474_CR41","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2265.2000.00983.x","volume":"52","author":"G Gambelunghe","year":"2000","unstructured":"G. Gambelunghe, F. Forini, S. Laureti, G. Murdolo, G. Toraldo, F. Santeusanio, P. Brunetti, C.B. Sanjeevi, A. Falorni, Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clin. Endocrinol. (Oxford) 52(5), 565\u2013573 (2000). (LoE )","journal-title":"Clin. Endocrinol. (Oxford)"},{"issue":"2\u20133","key":"474_CR42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0168-8227(00)00146-7","volume":"49","author":"C Rattarasarn","year":"2000","unstructured":"C. Rattarasarn, M.A. Diosdado, J. Ortego, R. Leelawattana, S. Soonthornpun, W. Setasuban, S. Jaruratanasirikul, N. Patarakijvanich, Thyroid autoantibodies in Thai type 1 diabetic patients: clinical significance and their relationship with glutamic acid decarboxylase antibodies. Diabetes Res. Clin. Pract. 49(2\u20133), 107\u2013111 (2000). (LoE )","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"2","key":"474_CR43","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1365-2249.2001.01668.x","volume":"126","author":"CE Block De","year":"2001","unstructured":"C.E. De Block, I.H. De Leeuw, J.J. Vertommen, R.P. Rooman, M.V. Du Caju, C.M. Van Campenhout, J.J. Weyler, F. Winnock, J. Van Autreve, F.K. Gorus, Belgian Diabetes Registry, Beta-cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA-DQ types in type 1 diabetes. Clin. Exp. Immunol. 126(2), 236\u2013241 (2001). (LoE )","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"474_CR44","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.2337\/diacare.25.8.1346","volume":"25","author":"O Kordonouri","year":"2002","unstructured":"O. Kordonouri, A. Klinghammer, E.B. Lang, A. Gr\u00fcters-Kieslich, M. Grabert, R.W. Holl, Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. Diabetes Care 25(8), 1346\u20131350 (2002). (Loe )","journal-title":"Diabetes Care"},{"issue":"3","key":"474_CR45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.33549\/physiolres.930485","volume":"53","author":"H B\u00e1rov\u00e1","year":"2004","unstructured":"H. B\u00e1rov\u00e1, J. Perusicov\u00e1, M. Hill, I. Sterzl, K. Vondra, Z. Masek, Anti-GAD-positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD-negative patients with type 1 and type 2 diabetes mellitus. Physiol. Res. 53(3), 279\u2013286 (2004). (LoE )","journal-title":"Physiol. Res."},{"issue":"1","key":"474_CR46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.33549\/physiolres.930544","volume":"54","author":"M Pr\u00e1zn\u00fd","year":"2005","unstructured":"M. Pr\u00e1zn\u00fd, J. Skrha, Z. L\u00edmanov\u00e1, Z. Van\u00edckov\u00e1, J. Hilgertov\u00e1, J. Pr\u00e1zn\u00e1, M. Jaresov\u00e1, I. Str\u00edz, Screening for associated autoimmunity in type 1 diabetes mellitus with respect to diabetes control. Physiol. Res. 54(1), 41\u201348 (2005). (LoE )","journal-title":"Physiol. Res."},{"issue":"7","key":"474_CR47","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1055\/s-2005-865769","volume":"113","author":"K Vondra","year":"2005","unstructured":"K. Vondra, J. Vrb\u00edkov\u00e1, B. Bendlov\u00e1, K. Dvorakova, I. Sterzl, M. Vondrova, Differences in type I diabetes mellitus of young adults with and without thyroid autoimmunity. Exp. Clin. Endocrinol. Diabetes 113(7), 404\u2013408 (2005). (LoE )","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"4","key":"474_CR48","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2337\/diacare.28.4.850","volume":"28","author":"JM Barker","year":"2005","unstructured":"J.M. Barker, J. Yu, L. Yu, J. Wang, D. Miao, F. Bao, E. Hoffenberg, J.C. Nelson, P.A. Gottlieb, M. Rewers, G.S. Eisenbarth, Autoantibody \u201csubspecificity\u201d in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care 28(4), 850\u2013855 (2005). (LoE )","journal-title":"Diabetes Care"},{"issue":"3","key":"474_CR49","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/dmrr.676","volume":"23","author":"H V\u00f6lzke","year":"2007","unstructured":"H. V\u00f6lzke, U. Krohn, H. Wallaschofski, J. L\u00fcdemann, U. John, W. Kerner, The spectrum of thyroid disorders in adult type 1 diabetes mellitus. Diabetes Metab. Res. Rev. 23(3), 227\u2013233 (2007). (LoE )","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"6","key":"474_CR50","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1515\/JPEM.2007.20.6.669","volume":"20","author":"RM Mantovani","year":"2007","unstructured":"R.M. Mantovani, L.M. Mantovani, V.M. Dias, Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus: prevalence and risk factors. J. Pediatr. Endocrinol. Metab. 20(6), 669\u2013675 (2007). (LoE )","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"9","key":"474_CR51","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.2337\/dc10-0404","volume":"33","author":"K Warncke","year":"2010","unstructured":"K. Warncke, E.E. Fr\u00f6hlich-Reiterer, A. Thon, S.E. Hofer, D. Wiemann, R.W. Holl, DPV Initiative of the German Working Group for Pediatric Diabetology, German BMBF Competence Network for Diabetes Mellitus, DPV Initiative of the German Working Group for Pediatric Diabetology, German BMBF Competence Network for Diabetes Mellitus, Polyendocrinopathy in children, adolescents, and young adults with type 1 diabetes: a multicenter analysis of 28,671 patients from the German\/Austrian DPV-Wiss database. Diabetes Care 33(9), 2010\u20132012 (2010). doi: 10.2337\/dc10-0404","journal-title":"Diabetes Care"},{"key":"474_CR52","doi-asserted-by":"crossref","unstructured":"R. Volp\u00e9, Autoimmunity in the Endocrine System, in Monographs on Endocrinology (Springer-Verlag, Berlin-Heidelberg-New York, (1981)), pp. 19\u2013111. (no LoE)","DOI":"10.1007\/978-3-642-81624-6_2"},{"issue":"5","key":"474_CR53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1530\/eje.0.1370503","volume":"137","author":"D Maugendre","year":"1997","unstructured":"D. Maugendre, F. V\u00e9rit\u00e9, I. Guilhem, B. Genetet, H. Allannic, M. Delamaire, Anti-pancreatic autoimmunity and Graves\u2019 disease: study of a cohort of 600 Caucasian patients. Eur. J. Endocrinol. 137(5), 503\u2013510 (1997). (LoE )","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"474_CR54","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/bjo.83.4.463","volume":"83","author":"R Kalmann","year":"1999","unstructured":"R. Kalmann, M.P. Mourits, Diabetes mellitus: a risk factor in patients with Graves\u2019 orbitopathy. Br. J. Ophthalmol. 83(4), 463\u2013465 (1999). (LoE )","journal-title":"Br. J. Ophthalmol."},{"issue":"2","key":"474_CR55","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2337\/diab.26.2.138","volume":"26","author":"WJ Irvine","year":"1977","unstructured":"W.J. Irvine, C.J. McCallum, R.S. Gray, C.J. Campbell, L.J. Duncan, J.W. Farquhar, H. Vaughan, P.J. Morris, Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes coexistent autoimmune disease, and HLA type. Diabetes 26(2), 138\u2013147 (1977). (LoE )","journal-title":"Diabetes"},{"issue":"1","key":"474_CR56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0022-3476(82)80227-8","volume":"100","author":"GM Bright","year":"1982","unstructured":"G.M. Bright, R.M. Blizzard, D.L. Kaiser, W.L. Clarke, Organ-specific autoantibodies in children with common endocrine diseases. J. Pediatr. 100(1), 8\u201314 (1982). (LoE )","journal-title":"J. Pediatr."},{"issue":"5","key":"474_CR57","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/BF00299020","volume":"30","author":"C Betterle","year":"1987","unstructured":"C. Betterle, F. Presotto, B. Pedini, L. Moro, R.S. Slack, F. Zanette, R. Zanchetta, Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value in the development of type 1 (insulin-dependent) diabetes mellitus. A ten year follow-up study. Diabetologia 30(5), 292\u2013297 (1987). (LoE )","journal-title":"Diabetologia"},{"issue":"3","key":"474_CR58","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2337\/diab.40.3.319","volume":"40","author":"Y Yamaguchi","year":"1991","unstructured":"Y. Yamaguchi, N. Chikuba, Y. Ueda, H. Yamamoto, H. Yamasaki, T. Nakanishi, S. Akazawa, S. Nagataki, Islet cell antibodies in patients with autoimmune thyroid diseases. Diabetes 40(3), 319\u2013322 (1991). (LoE )","journal-title":"Diabetes"},{"issue":"1","key":"474_CR59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00428784","volume":"37","author":"C Betterle","year":"1994","unstructured":"C. Betterle, F. Presotto, L. Magrin, B. Pedini, L. Moro, A. Caretto, R. Zanchetta, The natural history of pre-type 1 (insulin-dependent) diabetes mellitus in patients with autoimmune endocrine diseases. Diabetologia 37(1), 95\u2013103 (1994). (Loe )","journal-title":"Diabetologia"},{"issue":"1","key":"474_CR60","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2796.1996.417758000.x","volume":"239","author":"B Hallengren","year":"1996","unstructured":"B. Hallengren, A. Falorni, M. Landin-Olsson, A. Lernmark, K.I. Papadopoulos, G. Sundkvist, Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients at diagnosis and following treatment. J. Intern. Med. 239(1), 63\u201368 (1996). (LoE )","journal-title":"J. Intern. Med."},{"issue":"5","key":"474_CR61","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1006\/jaut.1995.0047","volume":"8","author":"E Kawasaki","year":"1995","unstructured":"E. Kawasaki, N. Abiru, M. Yano, S. Uotani, K. Matsumoto, H. Matsuo, H. Yamasaki, H. Yamamoto, Y. Yamaguchi, S. Akazawa, Autoantibodies in patients with autoimmune thyroid disease: relation to competitive insulin antibodies. J. Autoimmun. 8(5), 633\u2013643 (1995). (LoE ) doi: 10.1006\/jaut.1995.0047","journal-title":"J. Autoimmun."},{"issue":"8","key":"474_CR62","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/s-2006-924153","volume":"114","author":"DY Aksoy","year":"2006","unstructured":"D.Y. Aksoy, B.P. Y\u00fcrekli, B.O. Yildiz, O. Gedik, Prevalence of glutamic acid decarboxylase antibody positivity and its association with insulin secretion and sensitivity in autoimmune thyroid disease: a pilot study. Exp. Clin. Endocrinol. Diabetes 114(8), 412\u2013416 (2006). (LoE )","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"2","key":"474_CR63","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2337\/diacare.20.2.208","volume":"20","author":"M Pietropaolo","year":"1997","unstructured":"M. Pietropaolo, J.C. Hutton, G.S. Eisenbarth, Protein thyrosine phoshatase-like proteins: link with IDDM. Diabetes Care 20(2), 208\u2013214 (1997). (no LoE)","journal-title":"Diabetes Care"},{"issue":"4","key":"474_CR64","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/08916939708994729","volume":"25","author":"NG Morgenthaler","year":"1997","unstructured":"N.G. Morgenthaler, J. Seissler, P. Achenbach, D. Glawe, M. Payton, H.M. Meinck, M.R. Christie, W.A. Scherbaum, Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or Stiff man syndrome. Autoimmunity 25(4), 203\u2013211 (1997). (LoE )","journal-title":"Autoimmunity"},{"issue":"8","key":"474_CR65","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2337\/diab.40.8.977","volume":"40","author":"E Bosi","year":"1991","unstructured":"E. Bosi, F. Becker, E. Bonifacio, R. Wagner, P. Collins, E.A. Gale, G. Bottazzo, Progression to type 1 diabetes in autoimmune endocrine patients with islet cell antibodies. Diabetes. 40(8), 977\u2013984 (1991). (Loe )","journal-title":"Diabetes."},{"issue":"5","key":"474_CR66","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/AOG.0b013e318250aeeb","volume":"119","author":"CM Tudela","year":"2012","unstructured":"C.M. Tudela, B.M. Casey, D.D. McIntire, F.G. Cunningham, Relationship of subclinical thyroid disease to the incidence of gestational diabetes. Obstet. Gynecol. 119(5), 983\u2013988 (2012). (LoE ) doi: 10.1097\/AOG.0b013e318250aeeb","journal-title":"Obstet. Gynecol."},{"key":"474_CR67","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1749-6632.2002.tb02986.x","volume":"958","author":"C Betterle","year":"2002","unstructured":"C. Betterle, A.C. Spadaccino, F. Presotto, R. Zanchetta, B. Pedini, M. Lai, N.A. Greggio, G.F. Bottazzo, The number of markers of pancreatic autoimmunity increases the risk for type 1 diabetes mellitus (DM) in Italian and English patients with organ-specific autoimmune diseases (OSAD). Ann. N. Y. Acad. Sci. 958, 276\u2013280 (2002). (LoE )","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"8","key":"474_CR68","first-page":"1046","volume":"25","author":"AR Radaideh","year":"2004","unstructured":"A.R. Radaideh, M.K. Nusier, F.L. Amari, A.E. Bateiha, M.S. El-Khateeb, A.S. Naser, K.M. Ajlouni, Thyroid dysfunction in patients with type 2 diabetes mellitus in Jordan. Saudi Med. J. 25(8), 1046\u20131050 (2004). (LoE )","journal-title":"Saudi Med. J."},{"issue":"4","key":"474_CR69","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2265.2005.02246.x","volume":"62","author":"SAP Chubb","year":"2005","unstructured":"S.A.P. Chubb, W.A. Davis, Z. Inman, T.M. Davis, Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study. Clin. Endocrinol. (Oxford) 62(4), 480\u2013486 (2005). (Loe )","journal-title":"Clin. Endocrinol. (Oxford)"},{"issue":"1","key":"474_CR70","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1464-5491.2002.00635.x","volume":"19","author":"A Mohn","year":"2002","unstructured":"A. Mohn, S. Di Michele, R. Di Luzio, S. Tumini, F. Chiarelli, The effect of subclinical hypothyroidism on metabolic control in children and adolescents with type 1 diabetes mellitus. Diabet. Med. 19(1), 70\u201373 (2002). (LoE )","journal-title":"Diabet. Med."},{"issue":"12","key":"474_CR71","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1464-5491.2012.03687.x","volume":"29","author":"JJ D\u00edez","year":"2012","unstructured":"J.J. D\u00edez, P. Iglesias, An analysis of the relative risk for hypothyroidism in patients with Type 2 diabetes. Diabet. Med. 29(12), 1510\u20131514 (2012). (Loe ) doi: 10.1111\/j.1464-5491.2012.03687.x","journal-title":"Diabet. Med."},{"issue":"1","key":"474_CR72","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12020-012-9621-3","volume":"42","author":"JJ D\u00edez","year":"2012","unstructured":"J.J. D\u00edez, P. Iglesias, Subclinical hyperthyroidism in patients with type 2 diabetes. Endocrine 42(1), 157\u2013163 (2012). (LoE ) doi: 10.1007\/s12020-012-9621-3","journal-title":"Endocrine"},{"issue":"3","key":"474_CR73","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.diabres.2008.08.017","volume":"82","author":"B Gopinath","year":"2008","unstructured":"B. Gopinath, J.J. Wang, A. Kifley, J.R. Wall, S.R. Leeder, P. Mitchell, Type 2 diabetes does not predict incident thyroid dysfunction in the elderly. Diabetes Res. Clin. Pract. 82(3), e11\u2013e13 (2008). (LoE ) doi: 10.1016\/j.diabres.2008.08.017","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"4","key":"474_CR74","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0031-1271691","volume":"119","author":"JJ D\u00edez","year":"2011","unstructured":"J.J. D\u00edez, P. S\u00e1nchez, P. Iglesias, Prevalence of thyroid dysfunction in patients with type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 119(4), 201\u2013207 (2011). (LoE ) doi: 10.1055\/s-0031-1271691","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"6","key":"474_CR75","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/er.2008-0015","volume":"29","author":"A Huber","year":"2008","unstructured":"A. Huber, F. Menconi, S. Corathers, E.M. Jacobson, Y. Tomer, Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr. Rev. 29(6), 697\u2013725 (2008). doi: 10.1210\/er.2008-0015 . (no LoE)","journal-title":"Endocr. Rev."},{"issue":"2","key":"474_CR76","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/01.ede.0000193605.93416.df","volume":"17","author":"EC Somers","year":"2006","unstructured":"E.C. Somers, S.L. Thomas, L. Smeeth, A.J. Hall, Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology 17(2), 202\u2013217 (2006). (Loe )","journal-title":"Epidemiology"},{"issue":"4","key":"474_CR77","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/eje.0.1470443","volume":"147","author":"PR Gallas","year":"2002","unstructured":"P.R. Gallas, R.P. Stolk, K. Bakker, E. Endert, W.M. Wiersinga, Thyroid dysfunction during pregnancy and in the first postpartum year in women with diabetes mellitus type 1. Eur. J. Endocrinol. 147(4), 443\u2013451 (2002). (LoE )","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"474_CR78","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2337\/diacare.26.4.1235","volume":"26","author":"A Hanukoglu","year":"2003","unstructured":"A. Hanukoglu, A. Mizrachi, I. Dalal, O. Admoni, Y. Rakover, Z. Bistritzer, A. Levine, E. Somekh, D. Lehmann, M. Tuval, M. Boaz, A. Golander, Extrapancreatic autoimmune manifestations in type 1 diabetes patients and their first-degree relatives: a multicenter study. Diabetes Care. 26(4), 1235\u20131240 (2003). (LoE )","journal-title":"Diabetes Care."},{"issue":"6","key":"474_CR79","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2337\/dc06-2595","volume":"30","author":"GC Gonz\u00e0les","year":"2007","unstructured":"G.C. Gonz\u00e0les, I. Capel, J. Rodr\u00edguez-Espinosa, D. Mauricio, A. de Leiva, A. P\u00e9rez, Thyroid autoimmunity at onset of type 1 diabetes as a predictor of thyroid dysfunction. Diabetes Care 30(6), 1611\u20131612 (2007). (LoE )","journal-title":"Diabetes Care"},{"issue":"6","key":"474_CR80","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1464-5491.2002.00699.x","volume":"19","author":"O Kordonouri","year":"2002","unstructured":"O. Kordonouri, D. Deiss, T. Danne, A. Dorow, C. Bassir, A. Gr\u00fcters-Kieslich, Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with type 1 diabetes. Diabet. Med. 19(6), 518\u2013521 (2002). (LoE )","journal-title":"Diabet. Med."},{"issue":"4","key":"474_CR81","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/adc.2004.056424","volume":"90","author":"O Kordonouri","year":"2005","unstructured":"O. Kordonouri, R. Hartmann, D. Deiss, M. Wilms, A. Gr\u00fcters-Kieslich, Natural course of autoimmune thyroiditis in type 1 diabetes: association with gender, age, diabetes duration, and puberty. Arch. Dis. Child. 90(4), 411\u2013414 (2005). (LoE )","journal-title":"Arch. Dis. Child."},{"issue":"6","key":"474_CR82","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0022-2143(97)90108-6","volume":"130","author":"B Lindberg","year":"1997","unstructured":"B. Lindberg, U.B. Ericsson, R. Ljung, S.A. Ivarsson, High prevalence of thyroid autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children. J. Lab. Clin. Med. 130(6), 585\u2013589 (1997). (LoE )","journal-title":"J. Lab. Clin. Med."},{"issue":"4","key":"474_CR83","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1210\/jc.2008-2193","volume":"94","author":"MJB Villano","year":"2009","unstructured":"M.J.B. Villano, A.K. Huber, D.A. Greenberg, B.K. Golden, E. Concepcion, Y. Tomer, Autoimmune thyroiditis and diabetes: dissecting the joint genetic susceptibility in a large cohort of multiplex families. J. Clin. Endocrinol. Metab. 94(4), 1458\u20131466 (2009). (Loe ) doi: 10.1210\/jc.2008-2193","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"474_CR84","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ecl.2009.01.012","volume":"38","author":"SH Pearce","year":"2009","unstructured":"S.H. Pearce, T.R. Merriman, Genetics of type 1 diabetes and autoimmune thyroid disease. Endocrinol. Metab. Clin. North. Am. 38(2), 289\u2013301 (2009). doi: 10.1016\/j.ecl.2009.01.012 . vii-viii (no LoE)","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"issue":"11","key":"474_CR85","first-page":"376","volume":"67","author":"A Driessche Van den","year":"2009","unstructured":"A. Van den Driessche, V. Eenkhoorn, L. Van Gaal, C. De Block, Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review. Neth. J. Med. 67(11), 376\u2013387 (2009). (no LoE)","journal-title":"Neth. J. Med."},{"issue":"4","key":"474_CR86","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1210\/jc.2005-1679","volume":"91","author":"JM Barker","year":"2006","unstructured":"J.M. Barker, Clinical review: type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J. Clin. Endocrinol. Metab. 91(4), 1210\u20131217 (2006). (no LoE)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"20","key":"474_CR87","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJMra030158","volume":"350","author":"GS Eisenbarth","year":"2004","unstructured":"G.S. Eisenbarth, P.A. Gottlieb, Autoimmune polyendocrine syndromes. N. Engl. J. Med. 350(20), 2068\u20132079 (2004). (no LoE)","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 1","key":"474_CR88","first-page":"S11","volume":"35","author":"American Diabetes Association","year":"2012","unstructured":"American Diabetes Association, Standards of Medical Care in Diabetes 2012. Diabetes Care 35(Suppl 1), S11\u2013S63 (2012). doi: 10.2337\/dc12-s011 . (no LoE)","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"474_CR89","first-page":"S1","volume":"37","author":"Canadian Diabetes Association Clinical Practice Guidelines Expert Committee","year":"2013","unstructured":"Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can. J. Diabetes 37(suppl 1), S1\u2013S212 (2013). doi: 10.1016\/j.jcjd.2013.01.009 . (no LoE)","journal-title":"Can. J. Diabetes"},{"issue":"3","key":"474_CR90","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1530\/EJE-10-0419","volume":"163","author":"JM Dora","year":"2010","unstructured":"J.M. Dora, W.E. Machado, J. Rheinheimer, D. Crispim, A.L. Maia, Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case-control study and meta-analysis. Eur. J. Endocrinol. 163(3), 427\u2013434 (2010). (LoE ) doi: 10.1530\/EJE-10-0419","journal-title":"Eur. J. Endocrinol."},{"issue":"11","key":"474_CR91","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/archinte.1975.00330110067009","volume":"135","author":"HR Maxon","year":"1975","unstructured":"H.R. Maxon, K.W. Kreines, R.E. Goldsmith, H.C. Knowles Jr, Long-term observations of glucose tolerance in thyrotoxic patients. Arch. Intern. Med. 135(11), 1477\u20131480 (1975). (LoE )","journal-title":"Arch. Intern. Med."},{"key":"474_CR92","doi-asserted-by":"crossref","first-page":"439463","DOI":"10.4061\/2011\/439463","volume":"2011","author":"M Hage","year":"2011","unstructured":"M. Hage, M.S. Zantout, S.T. Azar, Thyroid disorders and diabetes mellitus. J. Thyroid Res. 2011, 439463 (2011). doi: 10.4061\/2011\/439463 . (no LoE)","journal-title":"J. Thyroid Res."},{"issue":"6","key":"474_CR93","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2362.1988.tb01275.x","volume":"18","author":"P Cavallo-Perin","year":"1988","unstructured":"P. Cavallo-Perin, A. Bruno, L. Boine, M. Cassader, G. Lenti, G. Pagano, Insulin resistance in Graves\u2019 disease: a quantitative in vivo evaluation. Eur. J. Clin. Invest. 18(6), 607\u2013613 (1988). (LoE )","journal-title":"Eur. J. Clin. Invest."},{"issue":"4","key":"474_CR94","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1530\/EJE-10-0246","volume":"163","author":"E Maratou","year":"2010","unstructured":"E. Maratou, D.J. Hadjidakis, M. Peppa, M. Alevizaki, K. Tsegka, V. Lambadiari, P. Mitrou, E. Boutati, A. Kollias, T. Economopoulos, S.A. Raptis, G. Dimitriadis, Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism. Eur. J. Endocrinol. 163(4), 625\u2013630 (2010). (LoE )doi: 10.1530\/EJE-10-0246","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"474_CR95","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1530\/EJE-09-0622","volume":"162","author":"P Mitrou","year":"2010","unstructured":"P. Mitrou, E. Boutati, V. Lambadiari, A. Tsegka, A.E. Raptis, N. Tountas, T. Economopoulos, S.A. Raptis, G. Dimitriadis, Insulin resistance in hyperthyroidism: the role of IL6 and TNF alpha. Eur. J. Endocrinol. 162(1), 121\u2013126 (2010). (LoE ) doi: 10.1530\/EJE-09-0622","journal-title":"Eur. J. Endocrinol."},{"issue":"883","key":"474_CR96","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/pgmj.75.883.291","volume":"75","author":"A Bhattacharyya","year":"1999","unstructured":"A. Bhattacharyya, P.G. Wiles, Diabetic ketoacidosis precipitated by thyrotoxicosis. Postgrad. Med. J. 75(883), 291\u2013292 (1999). (LoE )","journal-title":"Postgrad. Med. J."},{"issue":"2","key":"474_CR97","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4158\/EP.12.2.121","volume":"12","author":"KA Al-Shoumer","year":"2006","unstructured":"K.A. Al-Shoumer, B.A. Vasanthy, M.M. Al-Zaid, Effects of treatment of hyperthyroidism on glucose homeostasis, insulin secretion, and markers of bone turnover. Endocr. Pract. 12(2), 121\u2013130 (2006). (LoE )","journal-title":"Endocr. Pract."},{"issue":"4","key":"474_CR98","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s005920200040","volume":"39","author":"E Sol\u00e0","year":"2002","unstructured":"E. Sol\u00e0, C. Morillas, S. Garz\u00f3n, M. G\u00f3mez-Balaguer, A. Hern\u00e1ndez-Mijares, Association between diabetic ketoacidosis and thyrotoxicosis. Acta. Diabetol. 39(4), 235\u2013237 (2002). (LoE )","journal-title":"Acta. Diabetol."},{"issue":"1","key":"474_CR99","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2337\/diacare.24.1.171","volume":"24","author":"M Kunishige","year":"2001","unstructured":"M. Kunishige, E. Sekimoto, M. Komatsu, Y. Bando, H. Uehara, K. Izumi, Thyrotoxicosis masked by diabetic ketoacidosis: a fatal complication. Diabetes Care 24(1), 171 (2001). (LoE )","journal-title":"Diabetes Care"},{"issue":"6","key":"474_CR100","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2265.1978.tb02183.x","volume":"8","author":"R Naeije","year":"1978","unstructured":"R. Naeije, J. Golstein, N. Clumeck, H. Meinhold, K.W. Wenzel, L. Vanhaelst, A low T3 syndrome in diabetic ketoacidosis. Clin. Endocrinol. (Oxford) 8(6), 467\u2013472 (1978). (LoE )","journal-title":"Clin. Endocrinol. (Oxford)"},{"issue":"1","key":"474_CR101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.1.06131","volume":"187","author":"KK Boelaert","year":"2005","unstructured":"K.K. Boelaert, J.A. Franklyn, Thyroid hormone in health and disease. J. Endocrinol. 187(1), 1\u201315 (2005). (LoE )","journal-title":"J. Endocrinol."},{"issue":"11","key":"474_CR102","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJM199803123381103","volume":"338","author":"JA Franklin","year":"1998","unstructured":"J.A. Franklin, P. Maisonneuve, M.C. Sheppard, J. Betteridge, P. Boyle, Mortality after the treatment of hyperthyroidism with radioactive iodine. N. Engl. J. Med. 338(11), 712\u2013718 (1998). (LoE )","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"474_CR103","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3346\/jkms.2006.21.4.765","volume":"21","author":"SW Moon","year":"2006","unstructured":"S.W. Moon, J.R. Hahm, G.W. Lee, M.Y. Kang, J.H. Jung, T.S. Jung, K.W. Lee, K.A. Jung, Y.J. Ahn, S. Kim, M.A. Kim, D.R. Kim, S.I. Chung, M.H. Park, A case of hyperglycemic hyperosmolar state associated with Graves\u2019 hyperthyroidism: a case report. J. Korean Med. Sci. 21(4), 765\u2013767 (2006). (LoE )","journal-title":"J. Korean Med. Sci."},{"issue":"1","key":"474_CR104","first-page":"15","volume":"27","author":"MF Celani","year":"1994","unstructured":"M.F. Celani, M.E. Bonati, N. Stucci, Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus. Diabetes Res. 27(1), 15\u201325 (1994). (LoE )","journal-title":"Diabetes Res."},{"issue":"5","key":"474_CR105","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1530\/EJE-08-0797","volume":"160","author":"E Maratou","year":"2009","unstructured":"E. Maratou, D.J. Hadjidakis, A. Kollias, K. Tsegka, M. Peppa, M. Alevizaki, P. Mitrou, V. Lambadiari, E. Boutati, D. Nikzas, N. Tountas, T. Economopoulos, S.A. Raptis, G. Dimitriadis, Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur. J. Endocrinol. 160(5), 785\u2013790 (2009). (LoE ) doi: 10.1530\/EJE-08-0797","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"474_CR106","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/thy.2009.0108","volume":"19","author":"G Brenta","year":"2009","unstructured":"G. Brenta, F.S. Celi, M. Pisarev, M. Schnitman, I. Sinay, P. Arias, Acute thyroid hormone withdrawal in athyreotic patients results in a state of insulin resistance. Thyroid 19(6), 665\u2013669 (2009). (LoE ) doi: 10.1089\/thy.2009.0108","journal-title":"Thyroid"},{"issue":"4","key":"474_CR107","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1530\/acta.0.1200435","volume":"120","author":"H Debiec","year":"1989","unstructured":"H. Debiec, H.S. Cross, M. Peterlik, d-glucose uptake is increased in jejunal brush-border membrane vesicles from hyperthyroid chicks. Acta. Endocrinol. (Copenh) 120(4), 435\u2013441 (1989). (no LoE)","journal-title":"Acta. Endocrinol. (Copenh)"},{"issue":"6","key":"474_CR108","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1210\/jc.2003-030398","volume":"88","author":"AR Cappola","year":"2003","unstructured":"A.R. Cappola, P.W. Ladenson, Hypothyroidism and atherosclerosis. J. Clin. Endocrinol. Metab. 88(6), 2438\u20132444 (2003). (no LoE)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"474_CR109","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2217\/fca.10.126","volume":"7","author":"L Duntas","year":"2011","unstructured":"L. Duntas, G. Kolovou, Options for the treatment of hyperlipidemia in type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk. Future Cardiol. 7(2), 137\u2013144 (2011). doi: 10.2217\/fca.10.126 . (no LoE)","journal-title":"Future Cardiol."},{"key":"474_CR110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1752-1947-1-130","volume":"1","author":"E Yeter","year":"2007","unstructured":"E. Yeter, T. Keles, T. Durmaz, E. Bozkurt, Rhabdomyolysis due to the additive effect of statin therapy and hypothyroidism: a case report. J. Med. Case Rep. 1, 130 (2007). (LoE )","journal-title":"J. Med. Case Rep."},{"issue":"3","key":"474_CR111","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1507\/endocrj.K04-144","volume":"53","author":"K Tokinaga","year":"2006","unstructured":"K. Tokinaga, T. Oeda, Y. Suzuki, Y. Matsushima, HMG-CoA reductase inhibitors (statins) might cause high elevations of creatine phosphokinase (CK) in patients with unnoticed hypothyroidism. Endocr. J. 53(3), 401\u2013405 (2006). (LoE )","journal-title":"Endocr. J."},{"issue":"3","key":"474_CR112","first-page":"155","volume":"6","author":"MP Vanderpump","year":"1996","unstructured":"M.P. Vanderpump, W.M. Tunbridge, J.M. French, D. Appleton, D. Bates, F. Clark, J. Grimley Evans, H. Rodgers, F. Tunbridge, E.T. Youn, The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 6(3), 155\u2013160 (1996). (LoE )","journal-title":"Thyroid"},{"issue":"9","key":"474_CR113","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1210\/jc.2005-0298","volume":"90","author":"SA Chubb","year":"2005","unstructured":"S.A. Chubb, W.A. Davis, T.M. Davis, Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study. J. Clin. Endocrinol. Metab. 90(9), 5317\u20135320 (2005). (Loe )","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"474_CR114","first-page":"156","volume":"3","author":"KB Kapadia","year":"2012","unstructured":"K.B. Kapadia, P.A. Bhatt, J.S. Shah, Association between altered thyroid state and insulin resistance. J. Pharmacol. Pharmacother. 3(2), 156\u2013160 (2012). (LoE ) doi: 10.4103\/0976-500X.95517","journal-title":"J. Pharmacol. Pharmacother."},{"issue":"7","key":"474_CR115","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1210\/jc.2004-2225","volume":"90","author":"N Knudsen","year":"2005","unstructured":"N. Knudsen, P. Laurberg, L.B. Rasmussen, I. B\u00fclow, H. Perrild, L. Ovesen, T. J\u00f8rgensen, Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J. Clin. Endocrinol. Metab. 90(7), 4019\u20134024 (2005). (LoE )","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"474_CR116","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2265.2006.02433.x","volume":"64","author":"N Manji","year":"2006","unstructured":"N. Manji, K. Boelaert, M.C. Sheppard, R.L. Holder, S.C. Gough, J.A. Franklyn, Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects. Clin. Endocrinol. (Oxford) 64(2), 125\u2013128 (2006). (LoE )","journal-title":"Clin. Endocrinol. (Oxford)"},{"issue":"10","key":"474_CR117","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1210\/jc.2002-020493","volume":"87","author":"K Oboubie","year":"2002","unstructured":"K. Oboubie, J. Smith, L.M. Evans, R. John, J.S. Davies, J.H. Lazarus, Increased central arterial stiffness in hypothyroidism. J. Clin. Endocrinol. Metab. 87(10), 4662\u20134666 (2002). (LoE )","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"474_CR118","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1089\/thy.2007.0051","volume":"17","author":"PJ Owen","year":"2007","unstructured":"P.J. Owen, R. Sabit, J.H. Lazarus, Thyroid disease and vascular function. Thyroid 17, 519\u2013524 (2007)","journal-title":"Thyroid"},{"issue":"4","key":"474_CR119","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2265.1983.tb00018.x","volume":"19","author":"RS Gray","year":"1983","unstructured":"R.S. Gray, D.Q. Borsey, W.J. Irvine, J. Seth, B.F. Clarke, Natural history of thyroid function in diabetics with impaired thyroid reserve: a four year controlled study. Clin. Endocrinol. (Oxford) 19(4), 445\u2013451 (1983). (Loe )","journal-title":"Clin. Endocrinol. (Oxford)"},{"issue":"8","key":"474_CR120","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2337\/diacare.23.8.1201","volume":"23","author":"A Franzese","year":"2000","unstructured":"A. Franzese, P. Buono, M. Mascolo, A.L. Leo, G. Valerio, Thyroid autoimmunity starting during the course of type 1 diabetes denotes a subgroup of children with more severe diabetes. Diabetes Care 23(8), 1201\u20131202 (2000). (LoE )","journal-title":"Diabetes Care"},{"issue":"3","key":"474_CR121","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.2337\/dc09-1555","volume":"33","author":"T Sathyapalan","year":"2010","unstructured":"T. Sathyapalan, A.M. Manuchehri, A.S. Rigby, S.L. Atkin, Subclinical hypothyroidism is associated with reduced all-cause mortality in patients with type 2 diabetes. Diabetes Care 33(3), e37 (2010). (Loe ) doi: 10.2337\/dc09-1555","journal-title":"Diabetes Care"},{"issue":"4","key":"474_CR122","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-132-4-200002150-00004","volume":"132","author":"AE Hak","year":"2000","unstructured":"A.E. Hak, H.A. Pols, T.J. Visser, H.A. Drexhage, A. Hofman, J.C. Witteman, Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann. Intern. Med. 132(4), 270\u2013278 (2000). (Loe )","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"474_CR123","first-page":"2993","volume":"85","author":"MD Danese","year":"2000","unstructured":"M.D. Danese, P.W. Ladenson, C.L. Meinert, N.R. Powe, Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J. Clin. Endocrinol. Metab. 85(9), 2993\u20133001 (2000). (Loe )","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"474_CR124","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1464-5491.2007.02270.x","volume":"24","author":"HS Chen","year":"2007","unstructured":"H.S. Chen, T.E. Wu, T.S. Jap, R.A. Lu, M.L. Wang, R.L. Chen, H.D. Lin, Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in type 2 diabetic patients. Diabet. Med. 24(12), 1336\u20131344 (2007). (LoE )","journal-title":"Diabet. Med."},{"issue":"3\u20135","key":"474_CR125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000180514","volume":"15","author":"AI Katz","year":"1975","unstructured":"A.I. Katz, D.S. Emmanouel, M.D. Lindheimer, Thyroid hormone and the kidney. Nephron 15(3\u20135), 223\u2013249 (1975). (no LoE)","journal-title":"Nephron"},{"issue":"5","key":"474_CR126","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.2337\/dc09-1784","volume":"33","author":"JK Yang","year":"2010","unstructured":"J.K. Yang, W. Liu, J. Shi, Y.B. Li, An association between subclinical hypothyroidism and sight-threatening diabetic retinopathy in type 2 diabetic patients. Diabetes Care 33(5), 1018\u20131020 (2010). (LoE ) doi: 10.2337\/dc09-1784","journal-title":"Diabetes Care"},{"issue":"4","key":"474_CR127","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1620\/tjem.222.303","volume":"222","author":"GR Yang","year":"2010","unstructured":"G.R. Yang, J.K. Yang, L. Zhang, Y.H. An, J.K. Lu, Association between subclinical hypothyroidism and proliferative diabetic retinopathy in type 2 diabetic patients: a case-control study. Tohoku J. Exp. Med. 222(4), 303\u2013310 (2010). (Loe )","journal-title":"Tohoku J. Exp. Med."},{"issue":"5","key":"474_CR128","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0026-0495(89)90201-1","volume":"38","author":"RG Tilton","year":"1989","unstructured":"R.G. Tilton, G. Pugliese, K. Chang, A. Speedy, M.A. Province, C. Kilo, J.R. Williamson, Effects of hypothyroidism on vascular 125I-albumin permeation and blood flow in rats. Metabolism 38(5), 471\u2013478 (1989). (LoE )","journal-title":"Metabolism"},{"issue":"8","key":"474_CR129","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1210\/jc.2003-030039","volume":"88","author":"S Taddei","year":"2003","unstructured":"S. Taddei, N. Caraccio, A. Virdis, A. Dardano, D. Versari, L. Ghiadoni, A. Salvetti, E. Ferrannini, F. Monzani, Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J. Clin. Endocrinol. Metab. 88(8), 3731\u20133737 (2003). (LoE )","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"474_CR130","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/02713680500320711","volume":"30","author":"L Mutapcic","year":"2005","unstructured":"L. Mutapcic, S.M. Wren, D.A. Leske, M.P. Fautsch, J.M. Holmes, The effect of l-thyroxine supplementation on retinal vascular development in neonatal rats. Curr. Eye Res. 30(12), 1035\u20131040 (2005). (no LoE)","journal-title":"Curr. Eye Res."},{"issue":"7","key":"474_CR131","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4158\/EP13440.RA","volume":"20","author":"KA Toulis","year":"2014","unstructured":"K.A. Toulis, A. Stagnaro-Green, R. Negro, Maternal subclinical hypothyroidism and gestational diabetes mellitus: a meta analysis. Endocr. Pract. 20(7), 703\u2013714 (2014). (LoE ) doi: 10.4158\/EP13440.RA","journal-title":"Endocr. Pract."},{"issue":"6","key":"474_CR132","doi-asserted-by":"crossref","first-page":"419","DOI":"10.7326\/0003-4819-118-6-199303150-00004","volume":"118","author":"HC Gerstein","year":"1993","unstructured":"H.C. Gerstein, Incidence of postpartum thyroid dysfunction in patients with type 1 diabetes mellitus. Ann. Intern. Med. 118(6), 419\u2013423 (1993). (LoE )","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"474_CR133","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1080\/00016340802499261","volume":"87","author":"M Vestgaard","year":"2008","unstructured":"M. Vestgaard, L.R. Nielsen, A.K. Rasmussen, P. Damm, E.R. Mathiesen, Thyroid peroxidase antibodies in pregnant women with type 1 diabetes: impact on thyroid function, metabolic control and pregnancy outcome. Acta Obstet. Gynecol. Scand. 87(12), 1336\u20131342 (2008). (LoE ) doi: 10.1080\/00016340802499261","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"9","key":"474_CR134","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1210\/jc.2002-020524","volume":"87","author":"A Stagnaro-Green","year":"2002","unstructured":"A. Stagnaro-Green, Clinical review 152: postpartum thyroiditis. J. Clin. Endocrinol. Metab. 87(9), 4042\u20134047 (2002). (no LoE)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"474_CR135","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1210\/jc.2012-2540","volume":"97","author":"P Karakosta","year":"2012","unstructured":"P. Karakosta, D. Alegakis, V. Georgiou, T. Roumeliotaki, E. Fthenou, M. Vassilaki, D. Boumpas, E. Castanas, M. Kogevinas, L. Chatzi, Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. J. Clin. Endocrinol. Metab. 97(12), 4464\u20134472 (2012). (Loe ) doi: 10.1210\/jc.2012-2540","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"474_CR136","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1210\/jc.2011-2803","volume":"97","author":"L Groot De","year":"2012","unstructured":"L. De Groot, M. Abalovich, E.K. Alexander, N. Amino, L. Barbour, R.H. Cobin, C.J. Eastman, J.H. Lazarus, D. Luton, S.J. Mandel, J. Mestman, J. Rovet, S. Sullivan, Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 97(8), 2543\u20132565 (2012). doi: 10.1210\/jc.2011-2803 . (no LoE)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"474_CR137","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/diacare.13.7.801","volume":"13","author":"MJ McKenna","year":"1990","unstructured":"M.J. McKenna, R. Herskowitz, J.I. Wolfsdorf, Screening for thyroid disease in children with IDDM. Diabetes Care 13(7), 801\u2013803 (1990). (LoE )","journal-title":"Diabetes Care"},{"issue":"7","key":"474_CR138","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/02841850600806308","volume":"47","author":"R Junik","year":"2006","unstructured":"R. Junik, M. Kozinski, K. Debska-Kozinska, Thyroid ultrasound in diabetic patients without overt thyroid disease. Acta. Radiol. 47(7), 687\u2013691 (2006). (LoE )","journal-title":"Acta. Radiol."},{"issue":"3","key":"474_CR139","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/cen.12169","volume":"80","author":"JJ D\u00edez","year":"2014","unstructured":"J.J. D\u00edez, P. Iglesias, An analysis of the relative risk for goitre in euthyroid patients with type 2 diabetes. Clin. Endocrinol. (Oxford) 80(3), 356\u2013361 (2014). (LoE ) doi: 10.1111\/cen.12169","journal-title":"Clin. Endocrinol. (Oxford)"},{"key":"474_CR140","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10552-012-9896-y","volume":"23","author":"CM Kitahara","year":"2012","unstructured":"C.M. Kitahara, E.A. Platz, L.E. Beane Freeman, A. Black, A.W. Hsing, M.S. Linet, Y. Park, C. Schairer, A. Berrington de Gonz\u00e1lez, Physical activity, diabetes, and thyroid cancer risk: a pooled analysis of five prospective studies (2012). Cancer Causes Control 23, 463\u2013471 (2012). (Loe ) doi: 10.1007\/s10552-012-9896-y","journal-title":"Cancer Causes Control"},{"key":"474_CR141","first-page":"578285","volume":"2012","author":"SR Shih","year":"2012","unstructured":"S.R. Shih, W.Y. Chiu, T.C. Chang, C.H. Tseng, Diabetes and thyroid cancer risk: literature review. Exp. Diabetes Res. 2012, 578285 (2012). (Loe ) doi: 10.1155\/2012\/578285","journal-title":"Exp. Diabetes Res."},{"issue":"12","key":"474_CR142","doi-asserted-by":"crossref","first-page":"e53096","DOI":"10.1371\/journal.pone.0053096","volume":"7","author":"CH Tseng","year":"2012","unstructured":"C.H. Tseng, Thyroid cancer risk is not increased in diabetic patients. PLoS One 7(12), e53096 (2012). doi: 10.1371\/journal.pone.0053096","journal-title":"PLoS One"},{"issue":"1","key":"474_CR143","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00125-008-1157-y","volume":"52","author":"DM Nathan","year":"2009","unstructured":"D.M. Nathan, J.B. Buse, M.B. Davidson, E. Ferrannini, R.R. Holman, R. Sherwin, B. Zinman, American Diabetes Association, European Association for the Study of Diabetes, Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 52(1), 17\u201330 (2009). doi: 10.1007\/s00125-008-1157-y","journal-title":"Diabetologia"},{"issue":"1","key":"474_CR144","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1210\/jc.2005-1210","volume":"91","author":"RA Vigersky","year":"2006","unstructured":"R.A. Vigersky, A. Filmore-Nassar, A.R. Glass, Thyrotropin suppression by metformin. J. Clin. Endocrinol. Metab. 91(1), 225\u2013227 (2006). (LoE )","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"474_CR145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12020-007-9012-3","volume":"32","author":"ML Isidro","year":"2007","unstructured":"M.L. Isidro, M.A. Pen\u00edn, R. Nemi\u00f1a, F. Cordido, Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy. Endocrine 32(1), 79\u201382 (2007). (LoE )","journal-title":"Endocrine"},{"issue":"9","key":"474_CR146","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2337\/dc09-0273","volume":"32","author":"C Cappelli","year":"2009","unstructured":"C. Cappelli, M. Rotondi, I. Pirola, B. Agosti, E. Gandossi, U. Valentini, E. De Martino, A. Cimino, L. Chiovato, E. Agabiti-Rosei, M. Castellano, TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on l-T4 therapy patients. Diabetes Care 32(9), 1589\u20131590 (2009). (LoE ) doi: 10.2337\/dc09-0273","journal-title":"Diabetes Care"},{"issue":"4","key":"474_CR147","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2265.2012.04468.x","volume":"78","author":"JJ D\u00edez","year":"2013","unstructured":"J.J. D\u00edez, P. Iglesias, Relationship between serum thyrotropin concentrations and metformin therapy in euthyroid patients with type 2 diabetes. Clin. Endocrinol. (Oxford) 78(4), 505\u2013511 (2013). (LoE ) doi: 10.1111\/j.1365-2265.2012.04468.x","journal-title":"Clin. Endocrinol. (Oxford)"},{"issue":"8","key":"474_CR148","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1210\/jc.2012-3799","volume":"98","author":"J Klubo-Gwiezdzinska","year":"2013","unstructured":"J. Klubo-Gwiezdzinska, J. Costello Jr, A. Patel, A. Bauer, K. Jensen, M. Mete, K.D. Burman, L. Wartofsky, V. Vasko, Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer. J. Clin. Endocrinol. Metab. 98(8), 3269\u20133279 (2013). (LoE ) doi: 10.1210\/jc.2012-3799","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"474_CR149","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1210\/endo-67-3-293","volume":"67","author":"RE Tranquada","year":"1960","unstructured":"R.E. Tranquada, D.H. Solomon, J. Brown, R. Greene, The effect of oral hypoglycemic agents on thyroid function in the rat. Endocrinology. 67, 293\u2013297 (1960). (no LoE)","journal-title":"Endocrinology."},{"issue":"11","key":"474_CR150","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1210\/jcem-28-11-1605","volume":"28","author":"JM Hershman","year":"1968","unstructured":"J.M. Hershman, T.J. Craane, J.A. Colwell, Effect of sulfonylurea drugs on the binding of triiodothyronine and thyroxine to thyroxine-binding globulin. J. Clin. Endocrinol. Metab. 28(11), 1605\u20131610 (1968). (LoE )","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl 2","key":"474_CR151","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/0168-8227(91)90012-3","volume":"14","author":"C Kilo","year":"1991","unstructured":"C. Kilo, J. Dudley, B. Kalb, Evaluation of the efficacy and safety of Diamicron in non-insulin-dependent diabetic patients. Diabetes Res. Clin. Pract. 14(Suppl 2), S79\u2013S82 (1991). (LoE )","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"9","key":"474_CR152","first-page":"471","volume":"3","author":"ML England","year":"1986","unstructured":"M.L. England, J.M. Hartnell, J.M. Hershman, S.R. Levin, Glyburide does not alter thyroid function. Diabetes Res. 3(9), 471\u2013474 (1986). (LoE )","journal-title":"Diabetes Res."},{"issue":"14","key":"474_CR153","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM197704072961405","volume":"296","author":"SW Shen","year":"1977","unstructured":"S.W. Shen, R. Bressler, Clinical pharmacology of oral antidiabetic agents (second of two parts). N. Engl. J. Med. 296(14), 787\u2013793 (1977). (no LoE)","journal-title":"N. Engl. J. Med."},{"key":"474_CR154","first-page":"173","volume":"4","author":"B Efe","year":"1999","unstructured":"B. Efe, E. Entok, E. G\u00fcney, E. Ereno\u011flu, M. Kebap\u00e7\u0131, Effects of second generation sulfonylureas on the thyroid. Turk J. Endocrinol. Metab. 4, 173\u2013176 (1999). (no LoE)","journal-title":"Turk J. Endocrinol. Metab."},{"issue":"1","key":"474_CR155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1210\/jc.2002-020987","volume":"88","author":"K Starkey","year":"2003","unstructured":"K. Starkey, A. Heufelder, G. Baker, W. Joba, M. Evans, S. Davies, M. Ludgate, Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use? J. Clin. Endocrinol. Metab. 88(1), 55\u201359 (2003). (LoE )","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"474_CR156","first-page":"255","volume":"58","author":"R Menaka","year":"2010","unstructured":"R. Menaka, M. Sehgal, M. Lakshmi, A. Bhattacharyya, Thiazolidinedione precipitated thyroid associated ophthalmopathy. J. Assoc. Physicians India 58, 255\u2013257 (2010). (LoE )","journal-title":"J. Assoc. Physicians India"},{"key":"474_CR157","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2415-7-8","volume":"7","author":"S Lee","year":"2007","unstructured":"S. Lee, A. Tsirbas, R.A. Goldberg, J.D. McCann, Thiazolidinedione induced thyroid associated orbitopathy. BMC Ophthalmol. 7, 8 (2007). (LoE )","journal-title":"BMC Ophthalmol."},{"issue":"1","key":"474_CR158","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2265.2006.02542.x","volume":"65","author":"M Dorkhan","year":"2006","unstructured":"M. Dorkhan, M. Lantz, A. Frid, L. Groop, B. Hallengren, Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes. Clin. Endocrinol. (Oxford) 65(1), 35\u201339 (2006). (LoE )","journal-title":"Clin. Endocrinol. (Oxford)"},{"issue":"8","key":"474_CR159","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/07853890.2013.851865","volume":"45","author":"CH Tseng","year":"2013","unstructured":"C.H. Tseng, Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes. Ann. Med. 45(8), 539\u2013544 (2013). (LoE ) doi: 10.3109\/07853890.2013.851865","journal-title":"Ann. Med."},{"key":"474_CR160","unstructured":"Byetta (Package insert) Amylin Pharmaceuticals Inc. San Diego (2007) (no LoE)"},{"key":"474_CR161","unstructured":"Victoza US prescribing information (2010) www.victoza.com (no LoE)"},{"issue":"6","key":"474_CR162","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/dmrr.1202","volume":"27","author":"VR Aroda","year":"2011","unstructured":"V.R. Aroda, R. Ratner, The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a review. Diabetes Metab. Res. Rev. 27(6), 528\u2013542 (2011). doi: 10.1002\/dmrr.1202","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"7","key":"474_CR163","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2011-0599","volume":"96","author":"DJ Drucker","year":"2011","unstructured":"D.J. Drucker, S.I. Sherman, R.M. Bergenstal, J.B. Buse, The safety of incretin-based therapies\u2014review of the scientific evidence. J. Clin. Endocrinol. Metab. 96(7), 2027\u20132031 (2011). doi: 10.1210\/jc.2011-0599","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"474_CR164","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1210\/jc.2010-2318","volume":"96","author":"L Heged\u00fcs","year":"2011","unstructured":"L. Heged\u00fcs, A.C. Moses, M. Zdravkovic, T. Le Thi, G.H. Daniels, GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide. J. Clin. Endocrinol. Metab. 96(3), 853\u2013860 (2011). (LoE )","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"474_CR165","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2337\/diaspect.19.3.148","volume":"19","author":"JL Johnson","year":"2006","unstructured":"J.L. Johnson, Diabetes control in thyroid disease. Diabetes Spectr. 19, 148\u2013153 (2006). doi: 10.2337\/diaspect.19.3.148","journal-title":"Diabetes Spectr."},{"key":"474_CR166","doi-asserted-by":"crossref","unstructured":"K. Helms, K. Kelley, Drug-induced hypoglycaemia. Cases and Occurrence. (2011) www.intechopen.com (no LoE)","DOI":"10.5772\/23732"},{"issue":"3","key":"474_CR167","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1210\/jc.2008-1416","volume":"94","author":"MH Murad","year":"2009","unstructured":"M.H. Murad, F. Coto-Yglesias, A.T. Wang, N. Sheidaee, R.J. Mullan, M.B. Elamin, P.J. Erwin, V.M. Montori, Clinical review: drug-induced hypoglycemia: a systematic review. J. Clin. Endocrinol. Metab. 94(3), 741\u2013745 (2009). doi: 10.1210\/jc.2008-1416","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0474-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-014-0474-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0474-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T11:59:34Z","timestamp":1689681574000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-014-0474-9"}},"subtitle":["Diabetes mellitus and thyroid disorders: recommendations for clinical practice"],"short-title":[],"issued":{"date-parts":[[2014,11,18]]},"references-count":167,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["474"],"URL":"https:\/\/doi.org\/10.1007\/s12020-014-0474-9","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,18]]}}}